RAHUL MISHRA: Open Payments
NPI 1487881124 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 27 payments from 11 companies in 2025. Trend: 2023 $666 · 2024 $2,236 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $108 |
| BIOTRONIK NRO, Inc. | 4 | $68 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $68 |
| IBSA Pharma Inc. | 4 | $67 |
| Forte Bio-Pharma LLC | 2 | $53 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| SCILEX PHARMACEUTICALS INC. | 2 | $38 |
| Lundbeck LLC | 1 | $28 |
| ABBVIE INC. | 1 | $22 |
| Medtronic, Inc. | 1 | $14 |
Products named: JOURNAVX, Prospera, RELISTOR, Tirosint, PROLATE, XTAMPZA, ELYXYB - CELECOXIB, VYEPTI.
Industry payments across TX — which companies pay providers there.
